US$ 29.07
common side effects of glp-1 drugs Press Release Page Your guide to GLP-1 side
Description
Diabetes Obes Metab 22:938946

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of agents where use has surged in recent years, with global sales projected to reach $100 billion by 2030

Exenatide weekly, Liraglutide &Dulaglutide have the most reduction effect on HbA1c ( Table 3 ) Table 3: GLP-1RAs summary of head-to-head clinical trials

Table 4 lists the agents currently available in the USA and their dosing strategies [19, 38, 5558]

Real-world experience of adjunct weekly semaglutide in type 1 diabetes
